More
    Guided Solutions - Connecting Talent With Innovation/div>

    Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical

    Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn. The deal equates to the buyout...

    ZimVie to be acquired by Archimed in $730m deal

    ZimVie agreed to be acquired by an affiliate of the healthcare investment firm Archimed for $19 a share in cash, valuing the dental implant...

    Waters, BD Biosciences & Diagnostic Solutions to combine in $17.5B deal

    BD (NYSE: BDX)+ and Waters Corporation (NYSE:WAT) today announced a definitive agreement to create a new life science and diagnostics leader through a business...

    Innovia Medical acquires two US speciality medical device companies

    Innovia Medical has acquired Grace Medical and Hurricane Medical in the US, aimed at establishing a globally integrated platform of speciality surgical solutions. Grace Medical...

    RadNet acquires See-Mode to bolster AI ultrasound screening for thyroid cancer

    RadNet, a DeepHealth company, has acquired See-Mode, an artificial intelligence (AI)-based ultrasound imaging developer. The US company’s acquisition, the terms of which have not been...

    Highridge Medical sells Bone Healing unit to Avista

    Highridge Medical is going against the trend of shedding a spine unit in favor of focusing on stronger parts of the business. The spin-off spine...

    ElectroCore completes acquisition of NeuroMetrix

    ElectroCore completed its previously announced acquisition of NeuroMetrix. In December 2024, Rockaway, New Jersey-based ElectroCore struck a deal to acquire NeuroMetrix and its neuromodulation...

    Firefly Neuroscience acquires Evoke Neuroscience for $6m

    AI company Firefly Neuroscience has completed the acquisition of Evoke Neuroscience, a developer of technologies aimed at assessing brain health. This strategic move is said...

    Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7m

    Ypsomed announced it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million (CHF 420 million). Burgdorf, Switzerland–based Ypsomed says...

    Latest articles